SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025646
Filing Date
2023-09-12
Accepted
2023-09-12 09:15:21
Documents
13
Period of Report
2023-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20230908_8k.htm   iXBRL 8-K 21816
  Complete submission text file 0001437749-23-025646.txt   152879

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plse-20230910.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20230910_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20230910_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20230910_pre.xml EX-101.PRE 11584
7 EXTRACTED XBRL INSTANCE DOCUMENT plse20230908_8k_htm.xml XML 2555
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 231249119
SIC: 3841 Surgical & Medical Instruments & Apparatus